104 related articles for article (PubMed ID: 30266490)
1. Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma.
Kommalapati A; Tella SH; Goyal G; Borad M; Alberts SR; Roberts L; Hubbard JM; Durgin L; Cleary S; Mahipal A
HPB (Oxford); 2019 Mar; 21(3):379-386. PubMed ID: 30266490
[TBL] [Abstract][Full Text] [Related]
2. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.
Uhlig J; Sellers CM; Cha C; Khan SA; Lacy J; Stein SM; Kim HS
Ann Surg Oncol; 2019 Jul; 26(7):1993-2000. PubMed ID: 30693451
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
5. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.
Idrees JJ; Merath K; Gani F; Bagante F; Mehta R; Beal E; Cloyd JM; Pawlik TM
HPB (Oxford); 2019 Aug; 21(8):981-989. PubMed ID: 30591307
[TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
[TBL] [Abstract][Full Text] [Related]
7. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
8. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
9. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
Müller SA; Mehrabi A; Rahbari NN; Warschkow R; Elbers H; Leowardi C; Fonouni H; Tarantino I; Schemmer P; Schmied BM; Büchler MW
Ann Surg Oncol; 2014 Jan; 21(1):155-64. PubMed ID: 23982253
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
Zhao S; Wang J; Qin C
J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
[TBL] [Abstract][Full Text] [Related]
13. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma--a Texas Cancer Registry analysis.
Kneuertz PJ; Kao LS; Ko TC; Wray CJ
J Surg Oncol; 2014 Sep; 110(4):416-21. PubMed ID: 24889699
[TBL] [Abstract][Full Text] [Related]
14. Impact of intraoperative blood transfusion on short and long term outcomes after curative hepatectomy for intrahepatic cholangiocarcinoma: a propensity score matching analysis by the AFC-IHCC study group.
Gómez-Gavara C; Doussot A; Lim C; Salloum C; Lahat E; Fuks D; Farges O; Regimbeau JM; Azoulay D
HPB (Oxford); 2017 May; 19(5):411-420. PubMed ID: 28122668
[TBL] [Abstract][Full Text] [Related]
15. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
Pandey A; Pandey P; Ghasabeh MA; Zarghampour M; Khoshpouri P; Ameli S; Luo Y; Kamel IR
Radiology; 2018 Dec; 289(3):843-853. PubMed ID: 30129899
[TBL] [Abstract][Full Text] [Related]
16. Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery.
Yoh T; Hatano E; Nishio T; Seo S; Taura K; Yasuchika K; Okajima H; Kaido T; Uemoto S
World J Surg; 2016 Sep; 40(9):2229-36. PubMed ID: 27255940
[TBL] [Abstract][Full Text] [Related]
17. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
[TBL] [Abstract][Full Text] [Related]
18. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
Wang ML; Ke ZY; Yin S; Liu CH; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):110-116. PubMed ID: 30470543
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
20. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
